ホルモン補充療法用医薬品の世界市場レポート 2025年

ホルモン補充療法用医薬品の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.3％で171億米ドルに成長します。予測期間の成長は、ホルモン障害の罹患率の上昇、ヘルスケアインフラ、健康意識の高まり、患者教育、エンパワーメントに起因すると考えられます。予測期間の主な動向には、技術の進歩、個別化医療、研究開発、個別化ホルモン療法、代替送達方法、併用療法、遠隔医療と遠隔医療、デジタルヘルスソリューションなどがあります。

高齢化と閉経後の女性人口の増加が、ホルモン補充療法（HRT）薬市場の成長を牽引しています。エストロゲン、プロゲステロンなどを含むHRT医薬品は、閉経に伴う病状の治療に使用されます。例えば、米国を拠点とする政府機関である米国国勢調査局によると、2024年3月、2022年7月1日現在、米国には85歳以上の女性が約420万人います。更年期症状を経験する女性の増加と高齢化は、ホルモン補充療法用医薬品市場の成長に寄与する主な要因です。

ヘルスケア支出の増加は、ホルモン補充療法用医薬品市場の成長を促進します。ヘルスケア支出には、健康に焦点を当てた保健サービス、家族計画プログラム、栄養イニシアチブ、緊急支援などの提供に関連する費用が含まれます。ホルモン補充療法に対するヘルスケア支出の増加は、より良い患者アクセス、手頃な価格、より安全で効果的な治療法を開発するための研究をサポートします。例えば、2022年3月、米国を拠点とする連邦機関であるメディケア・メディケイド・サービスセンター（CMS）によると、国民医療費は2021年から2030年の間に毎年平均5.1％増加し、2030年には約6兆8,000億米ドルに達すると予測されています。したがって、医療費の増加がホルモン補充療法用医薬品市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ホルモン補充療法用医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のホルモン補充療法用医薬品市場：成長率分析
• 世界のホルモン補充療法用医薬品市場の実績：規模と成長, 2019-2024
• 世界のホルモン補充療法用医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界ホルモン補充療法用医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のホルモン補充療法用医薬品市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エストロゲン補充療法
• ヒト成長ホルモン（HGH）補充療法
• 甲状腺補充療法
• テストステロン補充療法
• 世界のホルモン補充療法用医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のホルモン補充療法用医薬品市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 甲状腺機能低下症
• 男性性腺機能低下症
• 成長ホルモン欠乏症
• 閉経
• その他の用途
• 世界のホルモン補充療法用医薬品市場エストロゲン補充療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口エストロゲン療法（エストラジオール、結合型エストロゲン）
• 経皮エストロゲン療法（エストラジオールパッチ）
• エストロゲンインプラント
• 膣エストロゲン療法（クリーム、錠剤、リング）
• 世界のホルモン補充療法用医薬品市場ヒト成長ホルモン（HGH）補充療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換えヒト成長ホルモン（ソマトロピン）
• 合成成長ホルモン製剤
• HGH注射
• 世界のホルモン補充療法用医薬品市場甲状腺補充療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• レボチロキシンナトリウム（合成T4）
• リオチロニンナトリウム（合成T3）
• 併用療法（T4とT3）
• 天然乾燥甲状腺（アーマー甲状腺）
• 世界のホルモン補充療法用医薬品市場テストステロン補充療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射用テストステロン（テストステロンエナント酸エステル、テストステロンシピオネート）
• 経皮テストステロン（パッチ、ジェル）
• 経口テストステロン（ウンデカン酸テストステロン）
• 口腔テストステロン
• テストステロンインプラント

第7章 地域別・国別分析

• 世界のホルモン補充療法用医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のホルモン補充療法用医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ホルモン補充療法用医薬品市場：競合情勢
• ホルモン補充療法用医薬品市場：企業プロファイル
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novo Nordisk AS Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Mylan N.V.
• Merck & Co.
• Hisamitsu Pharmaceutical Co. Inc.
• Teva Pharmaceutical Industries Ltd.
• F. Hoffmann-La Roche Ltd.
• Noven Pharmaceuticals Inc.
• Orion Pharma AB
• Allergan Plc
• QuatRx Pharmaceuticals
• Wyeth Ltd.
• Amgen Inc.
• Genentech USA Inc.
• TherapeuticsMD Inc.
• Viatris Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ホルモン補充療法用医薬品市場2029：新たな機会を提供する国
• ホルモン補充療法用医薬品市場2029：新たな機会を提供するセグメント
• ホルモン補充療法用医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hormonal replacement therapy drugs are used to treat individuals with growth hormone deficiency resulting from conditions such as dwarfism or menopause, a natural phase in a woman's life when her menstruation cycle ceases. These drugs play a vital role in replacing deficient hormones in the body, addressing issues related to growth hormone deficiency, and alleviating symptoms in menopausal women, including vaginal dryness, mood swings, bone weakening, and more.

The primary categories of hormonal replacement therapy drugs include estrogen replacement therapy, human growth hormone (HGH) replacement therapy, thyroid replacement therapy, and testosterone replacement therapy. These therapies can be administered through various routes, such as oral, parenteral (injections), and others. They are distributed through channels like hospital pharmacies, retail pharmacies, and online pharmacies, and are applied to treat conditions like hypothyroidism, male hypogonadism, growth hormone deficiency, menopause, and other related medical concerns.

The drugs for hormonal replacement therapy market research report is one of a series of new reports from The Business Research Company that provides drugs for hormonal replacement therapy market statistics, including drugs for hormonal replacement therapy industry global market size, regional shares, competitors with drugs for hormonal replacement therapy market share, detailed drugs for hormonal replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the drugs for hormonal replacement therapy industry. This drugs for hormonal replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drugs for hormonal replacement therapy market size has grown strongly in recent years. It will grow from $13.67 billion in 2024 to $14.45 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to aging population, increasing awareness, lifestyle factors, regulatory approvals, market globalization.

The drugs for hormonal replacement therapy market size is expected to see steady growth in the next few years. It will grow to $17.1 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to rising incidence of hormonal disorders, healthcare infrastructure, increasing health consciousness, patient education and empowerment. Major trends in the forecast period include technological advancements, personalized medicine, research and development, personalized hormone therapy, alternative delivery methods, combination therapies, telemedicine and telehealth, digital health solutions.

The growing population of aging and postmenopausal women is driving the growth of the hormonal replacement therapy (HRT) drugs market. HRT drugs, including estrogen, progesterone, and others, are used to treat medical conditions associated with menopause. For instance, in March 2024, according to the United States Census Bureau, a U.S.-based government agency, there were approximately 4.2 million females aged 85 and older in the United States as of July 1, 2022. The increasing number of women experiencing menopausal symptoms and the aging population are key factors contributing to the growth of the drugs for hormonal replacement therapy market.

The rise in healthcare expenditures is set to drive the growth of the drugs for hormonal replacement therapy market. Healthcare expenditures encompass the costs associated with delivering health services, family planning programs, nutrition initiatives, and emergency assistance with a focus on health. Increased healthcare spending on hormonal replacement therapy supports better patient access, affordability, and research to develop safer and more effective treatments. For instance, in March 2022, according to the Centers for Medicare and Medicaid Services (CMS), a U.S.-based federal agency, national health spending was projected to increase annually by an average of 5.1% between 2021 and 2030, reaching approximately $6.8 trillion by 2030. Therefore, the rise in healthcare expenditures is driving the growth of the drugs for hormonal replacement therapy market.

Major companies operating in the hormonal replacement therapy market are focusing on developing advanced solutions, such as new hormone replacement therapies, designed specifically for postmenopausal women with a uterus. New hormone replacement therapy (HRT) refers to innovative treatments that replace or balance hormones in the body, typically when natural hormone levels decline due to aging or medical conditions. For instance, in June 2023, Pfizer, a US-based pharmaceutical company, launched DUAVEE(R) (conjugated estrogens/bazedoxifene) to treat moderate to severe vasomotor symptoms associated with menopause, such as hot flashes, and to prevent postmenopausal osteoporosis. This product combines conjugated estrogens with bazedoxifene, a selective estrogen receptor modulator (SERM), rather than a progestin. This pairing helps reduce the risk of endometrial hyperplasia, which can occur with estrogen-alone therapies, offering a safer alternative for women with a uterus experiencing menopausal symptoms.

Major companies operating in the drugs for hormonal replacement therapy market are actively introducing novel medications such as VEOZAH to maximize their market revenue. VEOZAH is a non-hormonal medication that received approval from the FDA to treat moderate to severe vasomotor symptoms (VMS) due to menopause, targeting hot flashes and night sweats. For example, in May 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, secured FDA approval for VEOZAH to manage moderate to severe vasomotor symptoms (VMS) linked to menopause. Veozah is a non-hormonal medication designed to alleviate menopausal hot flashes and night sweats. It's the first neurokinin 3 (NK3) receptor antagonist approved by the FDA for treating moderate to severe menopausal hot flashes.

Major companies operating in the drugs for hormonal replacement therapy market include Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk AS, Eli Lilly and Company, Abbott Laboratories, Mylan N.V., Merck & Co., Hisamitsu Pharmaceutical Co. Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Noven Pharmaceuticals Inc., Orion Pharma AB, Allergan Plc, QuatRx Pharmaceuticals, Wyeth Ltd., Amgen Inc., Genentech USA Inc., TherapeuticsMD Inc., Viatris Inc., AbbVie Inc., GlaxoSmithKline plc, Sanofi S.A., Johnson & Johnson Services Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited

North America was the largest region in the drugs for hormonal replacement therapy market in 2024. The Middle East is expected to be the fastest-growing region in the drugs for hormonal replacement therapy market during the forecast period. The regions covered in the drugs for hormonal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drugs for hormonal replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The drugs for hormonal replacement therapy market includes revenues earned by entities by treating common menopausal symptoms, including hot flashes and vaginal discomfort. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drugs For Hormonal Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs for hormonal replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs for hormonal replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs for hormonal replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy Type: Estrogen Replacement Therapy; Human Growth Hormone (HGH) Replacement Therapy; Thyroid Replacement Therapy; Testosterone Replacement Therapy
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 3) By Application: Hypothyroidism; Male Hypogonadism; Growth Hormone Deficiency; Menopause; Other Applications
• Subsegments:
• 1) By Estrogen Replacement Therapy: Oral Estrogen Therapy (Estradiol, Conjugated Estrogens); Transdermal Estrogen Therapy (Estradiol Patches); Estrogen Implants; Vaginal Estrogen Therapy (Creams, Tablets, Rings)
• 2) By Human Growth Hormone (HGH) Replacement Therapy: Recombinant Human Growth Hormone (Somatropin); Synthetic Growth Hormone Preparations; HGH Injections
• 3) By Thyroid Replacement Therapy: Levothyroxine Sodium (Synthetic T4); Liothyronine Sodium (Synthetic T3); Combination Therapy (T4 and T3); Natural Desiccated Thyroid (Armour Thyroid)
• 4) By Testosterone Replacement Therapy: Injectable Testosterone (Testosterone Enanthate, Testosterone Cypionate); Transdermal Testosterone (Patches, Gels); Oral Testosterone (Testosterone Undecanoate); Buccal Testosterone; Testosterone Implants
• Companies Mentioned: Novartis AG; Bayer AG; Pfizer Inc.; Novo Nordisk AS; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drugs For Hormonal Replacement Therapy Market Characteristics

3. Drugs For Hormonal Replacement Therapy Market Trends And Strategies

4. Drugs For Hormonal Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Drugs For Hormonal Replacement Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drugs For Hormonal Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drugs For Hormonal Replacement Therapy Market Growth Rate Analysis
• 5.4. Global Drugs For Hormonal Replacement Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drugs For Hormonal Replacement Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drugs For Hormonal Replacement Therapy Total Addressable Market (TAM)

6. Drugs For Hormonal Replacement Therapy Market Segmentation

• 6.1. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrogen Replacement Therapy
• Human Growth Hormone (HGH) Replacement Therapy
• Thyroid Replacement Therapy
• Testosterone Replacement Therapy
• 6.2. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.3. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Menopause
• Other Applications
• 6.4. Global Drugs For Hormonal Replacement Therapy Market, Sub-Segmentation Of Estrogen Replacement Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Estrogen Therapy (Estradiol, Conjugated Estrogens)
• Transdermal Estrogen Therapy (Estradiol Patches)
• Estrogen Implants
• Vaginal Estrogen Therapy (Creams, Tablets, Rings)
• 6.5. Global Drugs For Hormonal Replacement Therapy Market, Sub-Segmentation Of Human Growth Hormone (HGH) Replacement Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Human Growth Hormone (Somatropin)
• Synthetic Growth Hormone Preparations
• HGH Injections
• 6.6. Global Drugs For Hormonal Replacement Therapy Market, Sub-Segmentation Of Thyroid Replacement Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Levothyroxine Sodium (Synthetic T4)
• Liothyronine Sodium (Synthetic T3)
• Combination Therapy (T4 and T3)
• Natural Desiccated Thyroid (Armour Thyroid)
• 6.7. Global Drugs For Hormonal Replacement Therapy Market, Sub-Segmentation Of Testosterone Replacement Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Testosterone (Testosterone Enanthate, Testosterone Cypionate)
• Transdermal Testosterone (Patches, Gels)
• Oral Testosterone (Testosterone Undecanoate)
• Buccal Testosterone
• Testosterone Implants

7. Drugs For Hormonal Replacement Therapy Market Regional And Country Analysis

• 7.1. Global Drugs For Hormonal Replacement Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drugs For Hormonal Replacement Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drugs For Hormonal Replacement Therapy Market

• 8.1. Asia-Pacific Drugs For Hormonal Replacement Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drugs For Hormonal Replacement Therapy Market

• 9.1. China Drugs For Hormonal Replacement Therapy Market Overview
• 9.2. China Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drugs For Hormonal Replacement Therapy Market

• 10.1. India Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drugs For Hormonal Replacement Therapy Market

• 11.1. Japan Drugs For Hormonal Replacement Therapy Market Overview
• 11.2. Japan Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drugs For Hormonal Replacement Therapy Market

• 12.1. Australia Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drugs For Hormonal Replacement Therapy Market

• 13.1. Indonesia Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drugs For Hormonal Replacement Therapy Market

• 14.1. South Korea Drugs For Hormonal Replacement Therapy Market Overview
• 14.2. South Korea Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drugs For Hormonal Replacement Therapy Market

• 15.1. Western Europe Drugs For Hormonal Replacement Therapy Market Overview
• 15.2. Western Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drugs For Hormonal Replacement Therapy Market

• 16.1. UK Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drugs For Hormonal Replacement Therapy Market

• 17.1. Germany Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drugs For Hormonal Replacement Therapy Market

• 18.1. France Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drugs For Hormonal Replacement Therapy Market

• 19.1. Italy Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drugs For Hormonal Replacement Therapy Market

• 20.1. Spain Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drugs For Hormonal Replacement Therapy Market

• 21.1. Eastern Europe Drugs For Hormonal Replacement Therapy Market Overview
• 21.2. Eastern Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drugs For Hormonal Replacement Therapy Market

• 22.1. Russia Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drugs For Hormonal Replacement Therapy Market

• 23.1. North America Drugs For Hormonal Replacement Therapy Market Overview
• 23.2. North America Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drugs For Hormonal Replacement Therapy Market

• 24.1. USA Drugs For Hormonal Replacement Therapy Market Overview
• 24.2. USA Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drugs For Hormonal Replacement Therapy Market

• 25.1. Canada Drugs For Hormonal Replacement Therapy Market Overview
• 25.2. Canada Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drugs For Hormonal Replacement Therapy Market

• 26.1. South America Drugs For Hormonal Replacement Therapy Market Overview
• 26.2. South America Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drugs For Hormonal Replacement Therapy Market

• 27.1. Brazil Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drugs For Hormonal Replacement Therapy Market

• 28.1. Middle East Drugs For Hormonal Replacement Therapy Market Overview
• 28.2. Middle East Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drugs For Hormonal Replacement Therapy Market

• 29.1. Africa Drugs For Hormonal Replacement Therapy Market Overview
• 29.2. Africa Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drugs For Hormonal Replacement Therapy Market Competitive Landscape And Company Profiles

• 30.1. Drugs For Hormonal Replacement Therapy Market Competitive Landscape
• 30.2. Drugs For Hormonal Replacement Therapy Market Company Profiles
  • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novo Nordisk AS Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Drugs For Hormonal Replacement Therapy Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Mylan N.V.
• 31.3. Merck & Co.
• 31.4. Hisamitsu Pharmaceutical Co. Inc.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. F. Hoffmann-La Roche Ltd.
• 31.7. Noven Pharmaceuticals Inc.
• 31.8. Orion Pharma AB
• 31.9. Allergan Plc
• 31.10. QuatRx Pharmaceuticals
• 31.11. Wyeth Ltd.
• 31.12. Amgen Inc.
• 31.13. Genentech USA Inc.
• 31.14. TherapeuticsMD Inc.
• 31.15. Viatris Inc.

32. Global Drugs For Hormonal Replacement Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drugs For Hormonal Replacement Therapy Market

34. Recent Developments In The Drugs For Hormonal Replacement Therapy Market

35. Drugs For Hormonal Replacement Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Drugs For Hormonal Replacement Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drugs For Hormonal Replacement Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drugs For Hormonal Replacement Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer